Cargando…
Development of Glycyrrhetinic Acid and Folate Modified Cantharidin Loaded Solid Lipid Nanoparticles for Targeting Hepatocellular Carcinoma
Cantharidin (CTD) is the major component of anticancer drugs obtained from Mylabris Cichorii and has a good inhibitory effect on several cancers, including hepatocellular carcinoma (HCC) and breast cancer. However, due to its toxicity, oral administration can cause various adverse reactions, limitin...
Autores principales: | Xu, Yilin, Wang, Min, Ning, Shuangcheng, Yang, Zhonglan, Zhou, Lili, Xia, Xinhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610810/ https://www.ncbi.nlm.nih.gov/pubmed/36296377 http://dx.doi.org/10.3390/molecules27206786 |
Ejemplares similares
-
Development of 11-DGA-3-O-Gal-Modified Cantharidin Liposomes for Treatment of Hepatocellular Carcinoma
por: Zhou, Lili, et al.
Publicado: (2019) -
Oral bioavailability of cantharidin-loaded solid lipid nanoparticles
por: Dang, Yun-Jie, et al.
Publicado: (2013) -
Preparation and In Vitro Evaluation of Glycyrrhetinic Acid-Modified Curcumin-Loaded Nanostructured Lipid Carriers
por: Chu, Yang, et al.
Publicado: (2014) -
Calorimetric Evaluation of Glycyrrhetic Acid (GA)- and Stearyl Glycyrrhetinate (SG)-Loaded Solid Lipid Nanoparticle Interactions with a Model Biomembrane
por: Santonocito, Debora, et al.
Publicado: (2021) -
Preparation of docetaxel-loaded, glycyrrhetinic acid-modified nanoparticles and their liver-targeting and antitumor activity
por: Xue, Hantao, et al.
Publicado: (2021)